Related references
Note: Only part of the references are listed.Therapeutic potential of Galectin-9 in human disease
Valerie R. Wiersma et al.
MEDICINAL RESEARCH REVIEWS (2013)
Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cells
Filiberto Cedeno-Laurent et al.
CLINICAL IMMUNOLOGY (2012)
Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner
Souichi Oomizu et al.
CLINICAL IMMUNOLOGY (2012)
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs
Shipra Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3+ Treg Development by Galectin-9 Secretion
Souichi Oomizu et al.
PLOS ONE (2012)
How mesenchymal stem cells interact with tissue immune responses
Yufang Shi et al.
TRENDS IN IMMUNOLOGY (2012)
Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study
Vinod K. Prasad et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Galectin-9 ameliorates acute GVH disease through the induction of T-cell apoptosis
Kazuki Sakai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Mesenchymal stromal cell 'licensing': a multistep process
M. Krampera
LEUKEMIA (2011)
Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells
Friederike Gieseke et al.
BLOOD (2010)
Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?
Karen English et al.
CELL STEM CELL (2010)
Modulation of Adult Mesenchymal Stem Cells Activity by Toll-Like Receptors: Implications on Therapeutic Potential
Olga DelaRosa et al.
MEDIATORS OF INFLAMMATION (2010)
Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy for the Treatment of Acute Graft-versus-Host Disease
Partow Kebriaei et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
The costimulatory role of TIM molecules
Roselynn Rodriguez-Manzanet et al.
IMMUNOLOGICAL REVIEWS (2009)
Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation
Gabriel A. Rabinovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide
Guangwen Ren et al.
CELL STEM CELL (2008)
Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
Masako Seki et al.
CLINICAL IMMUNOLOGY (2008)
Galectins: structure, function and therapeutic potential
Ri-Yao Yang et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
Structural features of galectin-9 and galectin-1 that determine distinct T cell death pathways
Shuguang Bi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4(+)CD25(high)FOXP3(+) regulatory T cells
Zohair Selmani et al.
STEM CELLS (2008)
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells
Ana C. Anderson et al.
SCIENCE (2007)
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
Dominique Chabannes et al.
BLOOD (2007)
Galectins in the tumor endothelium: opportunities for combined cancer therapy
Victor L. J. L. Thijssen et al.
BLOOD (2007)
Double-stranded RNA induces galectin-9 in vascular endothelial cells: involvement of TLR3, PI3K, and IRF3 pathway
Tadaatsu Imaizumi et al.
GLYCOBIOLOGY (2007)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity
C Zhu et al.
NATURE IMMUNOLOGY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Elevation of galectin-9 as an inflammatory response in the periodontal ligament cells exposed to Porphylomonas gingivalis lipopolysaccharide in vitro and in vivo
A Kasamatsu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance
CA Sabatos et al.
NATURE IMMUNOLOGY (2003)
Selective eosinophil adhesion to fibroblast via IFN-γ-induced galectin-9
A Hirofumi et al.
JOURNAL OF IMMUNOLOGY (2002)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
A system for stable expression of short interfering RNAs in mammalian cells
TR Brummelkamp et al.
SCIENCE (2002)
Regulation of galectin-9 expression and release in Jurkat T cell line cells
S Chabot et al.
GLYCOBIOLOGY (2002)
Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity
M Sato et al.
GLYCOBIOLOGY (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Galectin-9 in physiological and pathological conditions
M Hirashima et al.
GLYCOCONJUGATE JOURNAL (2002)
Share Paper
